Filing Details
- Accession Number:
- 0000315066-19-001467
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-03 17:07:51
- Reporting Period:
- 2019-04-01
- Accepted Time:
- 2019-04-03 17:07:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1357874 | Precision Biosciences Inc | DTIL | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-01 | 3,279,170 | $0.00 | 3,279,170 | No | 4 | C | Indirect | By F-Prime Capital Partners Healthcare Fund IV LP |
| Common Stock | Acquisiton | 2019-04-01 | 409,078 | $0.00 | 3,688,248 | No | 4 | C | Indirect | By F-Prime Capital Partners Healthcare Fund IV LP |
| Common Stock | Acquisiton | 2019-04-01 | 50,000 | $16.00 | 3,738,248 | No | 4 | P | Indirect | By F-Prime Capital Partners Healthcare Fund IV LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By F-Prime Capital Partners Healthcare Fund IV LP |
| No | 4 | C | Indirect | By F-Prime Capital Partners Healthcare Fund IV LP |
| No | 4 | P | Indirect | By F-Prime Capital Partners Healthcare Fund IV LP |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2019-04-01 | 7,000,000 | $0.00 | 3,279,170 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2019-04-01 | 873,253 | $0.00 | 409,078 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- On April 1, 2019, in connection with the completion of the issuer's initial public offering, each 2.134686 shares of Series A Preferred Stock and Series B Preferred Stock converted into 1 share of Common Stock.
Billionaire Hedge Funds
